Innate Pharma SA Revenue
Innate Pharma SA (IPHA) reported Revenue of EUR 9.01 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Income Statement › Other Income
ifrs-full:Revenue · last filed 2026-04-01
| Period end | Revenue 6 month | Revenue 6 month as first filed | Revenue 12 month | Revenue 12 month as first filed |
|---|---|---|---|---|
| 2025-12-31 | 9.01M EUR 20-F · filed 2026-04-01 | |||
| 2025-06-30 | 4.86M EUR 6-K · filed 2025-09-17 | |||
| 2024-12-31 | 20.12M EUR 20-F · filed 2026-04-01 | |||
| 2024-06-30 | 12.35M EUR 6-K · filed 2025-09-17 | |||
| 2023-12-31 | 61.64M EUR 20-F · filed 2026-04-01 | |||
| 2023-06-30 | 40.20M EUR 6-K · filed 2024-09-12 | |||
| 2022-12-31 | 57.67M EUR 20-F · filed 2025-04-30 | |||
| 2022-06-30 | 45.59M EUR 6-K · filed 2023-09-14 | |||
| 2021-12-31 | 24.70M EUR 20-F · filed 2024-04-04 | |||
| 2021-06-30 | 14.67M EUR 6-K · filed 2022-09-15 | 15.69M EUR 6-K · filed 2021-09-15 | ||
| 2020-12-31 | 69.77M EUR 20-F · filed 2023-04-06 | 70.45M EUR 20-F · filed 2021-04-27 | ||
| 2020-06-30 | 36.74M EUR 6-K · filed 2021-09-15 | |||
| 2019-12-31 | 85.45M EUR 20-F · filed 2022-04-04 | 85.81M EUR 20-F · filed 2020-04-24 | ||
| 2018-12-31 | 93.95M EUR 20-F · filed 2021-04-27 | |||
| 2017-12-31 | 44.03M EUR 20-F · filed 2020-04-24 |